Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Rhabdomyolysis and pigment nephropathy

Renal · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Rhabdomyolysis with hyperkalaemic ECG change, shock, severe acidosis, anuria, pulmonary oedema, heat stroke, limb ischaemia or compartment syndrome requires immediate ABCDE treatment, urgent surgical or critical-care involvement where indicated, and early nephrology input; do not wait for peak creatine kinase.

Synopsis

Recognise muscle breakdown before the classic triad appears, control its cause, prevent pigment-associated kidney injury and treat potassium, compartment and thermal emergencies without harmful routine adjuncts.

  • Rhabdomyolysis releases myoglobin, potassium, phosphate, urate and enzymes from injured skeletal muscle; kidney injury reflects pigment toxicity, tubular obstruction and the accompanying hypovolaemia or shock.
  • Common settings include crush or prolonged immobilisation, seizures, extreme exertion, hyperthermia, limb ischaemia, infection, metabolic disturbance, toxins and drug interactions involving statins.
  • Muscle pain, weakness and dark urine form a memorable triad but are often incomplete. Examine for swollen tender muscle, reduced limb perfusion, pressure injury and the precipitating neurological or thermal illness.
  • Urine dipstick detects haem pigment and may be strongly positive despite few or no red cells on microscopy, supporting myoglobinuria rather than urinary bleeding.
  • Creatine kinase confirms and tracks muscle injury but may rise and peak after presentation. The clinical cause, potassium, renal function, acid–base state and urine output determine immediate risk more directly than one CK number.
  • Early isotonic crystalloid is important when the patient is depleted and not congested, with repeated reassessment and an individual urine-output strategy; there is no universally safe fixed volume target.
  • Routine urinary alkalinisation with bicarbonate and routine mannitol are not established standard prophylaxis. Consider any exceptional use only with renal or critical-care oversight and a defined physiological indication.
  • Early hypocalcaemia often reflects calcium deposition in damaged muscle and should not be corrected solely by a laboratory value; give calcium for symptoms or a separate emergency indication, and anticipate rebound hypercalcaemia during recovery.

Key red flags

Traumatic or compression injury

Crush injury, entrapment, prolonged unconsciousness or pressure necrosis causes swollen tender muscle and systemic pigment release. Limb neurovascular compromise or pain out of proportion raises compartment syndrome and demands urgent surgical review.

Exertional or heat-related syndrome

Severe exercise, heat exposure, hyperthermia, collapse or altered cognition can precede rhabdomyolysis. Heat stroke is a critical illness requiring immediate cooling and multi-organ support, not merely intravenous fluid for a high CK.

Drug and toxin association

A statin interaction, stimulant, antipsychotic-associated hyperthermic syndrome, serotonin toxicity, alcohol or illicit drug exposure may be causal. Look for rigidity, autonomic features and co-ingestants rather than attributing all cases to the prescribed statin.

Electrolyte toxicity

Rapid potassium and phosphate release, metabolic acidosis and early hypocalcaemia can occur before kidney injury is fully visible. ECG change, weakness or arrhythmia determines emergency treatment, while later rebound hypercalcaemia can complicate recovery.

Investigation priorities

01
Serial creatine kinaseFirst step

Confirm significant skeletal-muscle injury and determine whether release is continuing or resolving.

Management branches

ImmediateStabilise pigment and electrolyte threat

Rhabdomyolysis is suspected from the setting, symptoms, pigment urine or elevated CK.

  1. 1. Perform ABCDE, obtain ECG, potassium, gas, renal profile, calcium, phosphate and CK, and begin continuous monitoring when hyperkalaemia or severe systemic illness is possible.
  2. 2. Treat hyperkalaemic membrane toxicity and redistribute potassium through the current UKKA emergency protocol while arranging definitive removal if refractory.
  3. 3. Restore circulating volume with isotonic crystalloid when examination supports depletion, reassessing pressure, lungs, urine output and cumulative balance after each phase.
  4. 4. Involve nephrology early for oliguria, rising potassium, acidosis or overload, because continued large-volume fluid may be unsafe and dialysis decisions are complication-based.

Key medicines

Intravenous isotonic crystalloidStart promptly when hypovolaemia or major pigment burden is present, using locally approved boluses and ongoing rates titrated to perfusion, urine output, weight and respiratory reassessment.No fixed multi-litre target is safe for every patient. Slow or stop when oliguria, heart failure or pulmonary congestion emerges; fluid cannot clear potassium or pigment when filtration has failed.
Intravenous calcium salt for hyperkalaemic cardiac toxicityGive the calcium preparation and repeat strategy specified in the current UKKA or local resuscitation protocol when ECG toxicity is present, with immediate rhythm reassessment.It does not lower serum potassium. Do not give solely for an asymptomatic early low calcium in rhabdomyolysis, and verify the local choice of calcium chloride versus gluconate and access requirements.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • UK Kidney Association acute kidney injury guidelineAKI prevention and management including pigment causes.
  • UK Kidney Association hyperkalaemia guidelineCurrent UK emergency potassium treatment and monitoring recommendations.
  • MHRA statins benefits and risksOfficial UK medicine safety discussion including muscle toxicity.
  • MHRA simvastatin drug interactionsOfficial interaction and myopathy risk advice.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom